Pharmacokinetics of Sativex(®) in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

The phytocannabinoid-based medicine Sativex(®) is currently marketed for the treatment of spasticity and pain in multiple sclerosis patients and is being investigated for other central and peripheral pathological conditions. It may also serve in Veterinary Medicine for the treatment of domestic anim...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Trapero, María, Pérez-Díaz, Carmen, Espejo-Porras, Francisco, de Lago, Eva, Fernández-Ruiz, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072526/
https://www.ncbi.nlm.nih.gov/pubmed/32054131
http://dx.doi.org/10.3390/biom10020279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072526/
https://www.ncbi.nlm.nih.gov/pubmed/32054131
http://dx.doi.org/10.3390/biom10020279

Ejemplares similares